Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' growth hormone levels.
Data(s) |
01/04/2006
|
---|---|
Identificador |
http://dx.doi.org/10.1111/j.1365-2265.2006.02480.x http://www.scopus.com/inward/record.url?scp=33644905284&partnerID=8YFLogxK |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Lindsay , J 2006 , ' Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' growth hormone levels. ' Clinical Endocrinology , vol 64(4) , no. 4 , pp. 475-476 . DOI: 10.1111/j.1365-2265.2006.02480.x |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/1300/1310 #Endocrinology |
Tipo |
article |